About Ross Silverman

Ross D. Silverman, JD, MPH, is Professor of Health Policy and Management at Indiana University Fairbanks School of Public Health and Professor of Public Health and Law at Indiana University McKinney School of Law in Indianapolis. He is a member of the IU Centers on Health Policy and Bioethics. His research focuses on public health and medical law, policy, and ethics, and law's impact on health outcomes and vulnerable populations. He also serves as Associate Editor on Legal Epidemiology for Public Health Reports, the official journal of the Office of the U.S. Surgeon General and the U.S. Public Health Service. His most recent Covid-19 publications include: "Ensuring Uptake of Vaccines Against SARS-CoV-2" in the New England Journal of Medicine (with MM Mello & SB Omer), and "Covid-19: control measures must be equitable and inclusive" in BMJ (with ZD Berger, NG Evans & AL Phelan)

Equity and the Vaccine Rollout “We don’t want equity and speed at odds with one another,” said California’s Health Secretary Mark Ghaly at a recent news conference. As the COVID-19 vaccine rollout approaches its third month, more information is now Read More
Biden White House Establishes National Covid-19 Response Priorities In an effort to better coordinate efforts to respond to a pandemic that has now resulted in more than 400,000 deaths, President Biden, within 24 hours of taking office, set out a Read More
Vaccine Allocation Equity The Robert Wood Johnson Foundation published a very simple but effective infographic to depict the difference between policies and interventions aimed at equality, and those seeking equity: Imagine instead of a bicycle, the example used: Access to Read More
MUST READ POLICY PIECES: This week, the New Yorker published “The Plague Year” by Lawrence Wright, a tour-de-force piece of reporting on the nation’s pandemic response. Having read a great deal of policy-related reporting on the outbreak, I believe this Read More
COVID-19 Vaccines  The Moderna COVID-19 vaccine received an Emergency Use Authorization from the Food and Drug Administration for use in adults. On Saturday, the Advisory Committee on Immunization Practices (ACIP), which offers guidance to the CDC concerning vaccine policy, unanimously Read More
Pfizer-BioNTech Covid-19 Vaccine Receives Emergency Use Authorization & ACIP Use Recommendation for People age 16 and older On Friday, December 11, 2020, the U.S. Food and Drug Administration (FDA) issued its first Emergency Use Authorization (EUA) for a Covid-19 Vaccine Read More
CDC 10-Step Pandemic Policy Response Plan, Recommends Enforcing Mask Mandates On Friday, the Centers for Disease Control released a new, evidence-based “urgent battle plan” offering recommendations to local policymakers and public health agencies on how to respond to a COVID-19 Read More
COVID-19 Vaccine In early December, the Food and Drug Administration is expected to complete its review and approve two new COVID-19 vaccines, meaning a limited number of doses of COVID-19 vaccines may begin to be distributed to states by as Read More
Infection Control Policies – Think Dials, Not Switches COVID-19 case numbers are skyrocketing, threatening to overwhelm not only local bed capacity but also, more dangerously, our health care workforce. Without enough workers to care for the ill, hospitals will face Read More
Testing & School Reopening Authors of a New England Journal of Medicine perspective this week propose that making routine Covid-19 testing available in schools should be a top national response priority, and they critique the lack of inclusion of testing Read More

Get Involved with Indiana CTSI